Stock investors have not been deterred by rising COVID-19 infection rates, increasing hospitalizations or a trio of pending decisions to address the growing pandemic. On Thursday, the FDA’s Vaccines and … Click to Continue »
Read more here:: Deadlines, decisions and investor enthusiasm | Opinion